Patented Cold Plasma Technology

A cleaner, safer way to treat what industries depend on.

NanoGuard Technologies develops patented cold plasma solutions that replace harsh, residue-heavy treatment methods with a modern, scalable platform — engineered for real-world industrial use.

2014Innovating Since
04Key Patents
5+Industry Applications
PLASMA · ACTIVE ~25°C · NON-THERMAL REACTIVE SPECIES SCALABLE
Since 2014 · Cold Plasma R&D 04 · Foundational Patents Platform · Multi-Industry Architecture Cleaner · Low-Residue Treatment
What We Do

A platform technology, not a point solution.

NanoGuard's cold plasma platform offers industries a controllable, low-residue alternative to legacy treatment methods such as toxic fumigants, harsh chemistries, and high-heat processes. Our technology is designed to scale — adaptable across applications where safety, cleanliness, and operational efficiency matter.

~25°C
Near-ambient operating temperature — non-thermal treatment
<1%
Chemical residue profile vs. conventional fumigation
5+
Industry verticals with active commercial relevance
Cold plasma reactor visualization
Our Technology

Cold plasma, engineered for industry.

Cold plasma is an ionized gas generated at near-ambient temperatures. It produces reactive species capable of decontaminating surfaces, materials, and flowing media — without the heat, residues, or toxicity of conventional chemical or thermal approaches.

NanoGuard's proprietary approach is built around indirect, scalable treatment — a design philosophy that prioritizes throughput, consistency, and operational integration. The result: a treatment method that fits modern industrial workflows instead of disrupting them.

Learn About the Technology
Intellectual Property

Four patents. One defensible platform.

NanoGuard's IP portfolio anchors the commercial defensibility of our technology and unlocks application across multiple industries.

PATENT · 01

Plasma Generation

Stable, controllable cold plasma production engineered for industrial-scale throughput and reliability.

Enables
Consistent reactive-species output
Significance
Foundational to platform scalability
PATENT · 02

Indirect Delivery

Treatment architecture that delivers plasma effects safely and uniformly across target media.

Enables
Safer operational environments
Significance
Differentiated treatment mechanism
PATENT · 03

Process Integration

System-level design enabling deployment within existing industrial workflows and facility footprints.

Enables
Faster commercial adoption
Significance
Lower integration barriers
PATENT · 04

Application Adaptation

Tunable parameters that adapt the platform to multiple industry use cases without redesign.

Enables
Multi-industry applicability
Significance
Platform economics
Explore All Patents →
Why NanoGuard

The modern alternative to harsh legacy methods.

Many industries still depend on treatment methods that are toxic to handle, leave residues behind, demand long cycle times, or carry growing regulatory pressure. NanoGuard offers an alternative built for where industry is heading.

01

Cleaner

Low- to no-residue treatment by design.

02

Safer

Reduced reliance on hazardous chemistry.

03

Faster

Engineered for efficient, integrated cycles.

04

Scalable

A platform technology, not a one-off device.

See Why NanoGuard →
Potential Markets

One platform. Multiple industries.

NanoGuard's cold plasma technology has commercial relevance across sectors where treatment quality, safety, and throughput drive value.

View All Potential Markets →
Start a Conversation

Interested in using cold plasma technology?

Whether you're evaluating a specific application, exploring a partnership, or simply want to understand how cold plasma could fit your operations — our team is ready to talk.

NanoGuard News

Studies, insights, and developments.

View All News →
StudyApril 2026

Cold plasma efficacy in grain mycotoxin reduction

Recent peer-reviewed findings on the effectiveness of cold plasma for treating mycotoxin contamination in stored grain.

Read more →
InsightMarch 2026

Why industries are rethinking legacy fumigation

Tightening regulation, ESG pressure, and worker safety are reshaping the economics of conventional treatment.

Read more →
CompanyFebruary 2026

Expanding the NanoGuard platform across new sectors

An update on commercial development priorities and partnership pipeline across grain, water, and cultivation.

Read more →